Methods This retrospective study included patients who underwent ESD between December
2016 and April 2023 with pathologically staged T1b EC. Patient demographics, tumor …

Methods This is a case series of patients who underwent ESD resection at the Kingston
Health Sciences Center (KHSC) for T1b esophageal adenocarcinoma (EA) or squamous …

Background and Aims The outcomes of endoscopic submucosal dissection (ESD) for T1b
esophageal cancer (EC) and its recurrence rates remain unclear in the West. Using a …

Introduction Endoscopic submucosal dissection (ESD) is a preferred treatment option for
superficial esophageal squamous cell carcinoma (SESCC). However, only few studies …

Background & Aims Esophagectomy is the standard treatment for early-stage esophageal
squamous cell carcinoma (EESCC), but patients who undergo this procedure have high …

During the last 2 decades, EAC has shown an increasing trend in incidence of diagnosis.
Yet overall survival for EAC remains disappointing with a poor 5-year survival rate. Early …

Objectives Few Western studies highlighted the outcomes of endoscopic submucosal
dissection (ESD) for early esophageal adenocarcinoma (EAC). Data regarding the …

Background With the continuous advent of magnifying endoscopy, endoscopic submucosal
dissection (ESD) has gradually become the mainstream treatment for early esophageal …

Background Although additional treatment is considered for patients with esophageal
squamous cell carcinoma (ESCC) invading into the muscularis mucosa (pT1a-MM) or …

Purpose Endoscopic submucosal dissection (ESD) is a widely performed procedure for
esophageal carcinoma when the depth of invasion reaches the epithelium and lamina …